233 related articles for article (PubMed ID: 34643971)
21. APOE immunotherapy reduces cerebral amyloid angiopathy and amyloid plaques while improving cerebrovascular function.
Xiong M; Jiang H; Serrano JR; Gonzales ER; Wang C; Gratuze M; Hoyle R; Bien-Ly N; Silverman AP; Sullivan PM; Watts RJ; Ulrich JD; Zipfel GJ; Holtzman DM
Sci Transl Med; 2021 Feb; 13(581):. PubMed ID: 33597265
[TBL] [Abstract][Full Text] [Related]
22. Genetic associations between cathepsin D exon 2 C-->T polymorphism and Alzheimer's disease, and pathological correlations with genotype.
Davidson Y; Gibbons L; Pritchard A; Hardicre J; Wren J; Tian J; Shi J; Stopford C; Julien C; Thompson J; Payton A; Thaker U; Hayes AJ; Iwatsubo T; Pickering-Brown SM; Pendleton N; Horan MA; Burns A; Purandare N; Lendon CL; Neary D; Snowden JS; Mann DM
J Neurol Neurosurg Psychiatry; 2006 Apr; 77(4):515-7. PubMed ID: 16543533
[TBL] [Abstract][Full Text] [Related]
23. Alzheimer's disease associated isoforms of human CD33 distinctively modulate microglial cell responses in 5XFAD mice.
Eskandari-Sedighi G; Crichton M; Zia S; Gomez-Cardona E; Cortez LM; Patel ZH; Takahashi-Yamashiro K; St Laurent CD; Sidhu G; Sarkar S; Aghanya V; Sim VL; Tan Q; Julien O; Plemel JR; Macauley MS
Mol Neurodegener; 2024 May; 19(1):42. PubMed ID: 38802940
[TBL] [Abstract][Full Text] [Related]
24. Comparative analysis of transcriptome remodeling in plaque-associated and plaque-distant microglia during amyloid-β pathology progression in mice.
Hemonnot-Girard AL; Meersseman C; Pastore M; Garcia V; Linck N; Rey C; Chebbi A; Jeanneteau F; Ginsberg SD; Lachuer J; Reynes C; Rassendren F; Hirbec H
J Neuroinflammation; 2022 Sep; 19(1):234. PubMed ID: 36153535
[TBL] [Abstract][Full Text] [Related]
25. Microglial mTOR Activation Upregulates Trem2 and Enhances β-Amyloid Plaque Clearance in the
Shi Q; Chang C; Saliba A; Bhat MA
J Neurosci; 2022 Jul; 42(27):5294-5313. PubMed ID: 35672148
[TBL] [Abstract][Full Text] [Related]
26. Microglial P2X4 receptors promote ApoE degradation and contribute to memory deficits in Alzheimer's disease.
Hua J; Garcia de Paco E; Linck N; Maurice T; Desrumaux C; Manoury B; Rassendren F; Ulmann L
Cell Mol Life Sci; 2023 May; 80(5):138. PubMed ID: 37145189
[TBL] [Abstract][Full Text] [Related]
27. Effects of microglial depletion and TREM2 deficiency on Aβ plaque burden and neuritic plaque tau pathology in 5XFAD mice.
Delizannis AT; Nonneman A; Tsering W; De Bondt A; Van den Wyngaert I; Zhang B; Meymand E; Olufemi MF; Koivula P; Maimaiti S; Trojanowski JQ; Lee VM; Brunden KR
Acta Neuropathol Commun; 2021 Sep; 9(1):150. PubMed ID: 34503586
[TBL] [Abstract][Full Text] [Related]
28. LPS priming before plaque deposition impedes microglial activation and restrains Aβ pathology in the 5xFAD mouse model of Alzheimer's disease.
Yang Y; García-Cruzado M; Zeng H; Camprubí-Ferrer L; Bahatyrevich-Kharitonik B; Bachiller S; Deierborg T
Brain Behav Immun; 2023 Oct; 113():228-247. PubMed ID: 37437821
[TBL] [Abstract][Full Text] [Related]
29. Dietary lipophilic iron alters amyloidogenesis and microglial morphology in Alzheimer's disease knock-in APP mice.
Peters DG; Pollack AN; Cheng KC; Sun D; Saido T; Haaf MP; Yang QX; Connor JR; Meadowcroft MD
Metallomics; 2018 Mar; 10(3):426-443. PubMed ID: 29424844
[TBL] [Abstract][Full Text] [Related]
30. Cell-autonomous effects of APOE4 in restricting microglial response in brain homeostasis and Alzheimer's disease.
Liu CC; Wang N; Chen Y; Inoue Y; Shue F; Ren Y; Wang M; Qiao W; Ikezu TC; Li Z; Zhao J; Martens Y; Doss SV; Rosenberg CL; Jeevaratnam S; Jia L; Raulin AC; Qi F; Zhu Y; Alnobani A; Knight J; Chen Y; Linares C; Kurti A; Fryer JD; Zhang B; Wu LJ; Kim BYS; Bu G
Nat Immunol; 2023 Nov; 24(11):1854-1866. PubMed ID: 37857825
[TBL] [Abstract][Full Text] [Related]
31. Immune hyperreactivity of Aβ plaque-associated microglia in Alzheimer's disease.
Yin Z; Raj D; Saiepour N; Van Dam D; Brouwer N; Holtman IR; Eggen BJL; Möller T; Tamm JA; Abdourahman A; Hol EM; Kamphuis W; Bayer TA; De Deyn PP; Boddeke E
Neurobiol Aging; 2017 Jul; 55():115-122. PubMed ID: 28434692
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of REV-ERBs stimulates microglial amyloid-beta clearance and reduces amyloid plaque deposition in the 5XFAD mouse model of Alzheimer's disease.
Lee J; Kim DE; Griffin P; Sheehan PW; Kim DH; Musiek ES; Yoon SY
Aging Cell; 2020 Feb; 19(2):e13078. PubMed ID: 31800167
[TBL] [Abstract][Full Text] [Related]
33. Critical role of astroglial apolipoprotein E and liver X receptor-α expression for microglial Aβ phagocytosis.
Terwel D; Steffensen KR; Verghese PB; Kummer MP; Gustafsson JÅ; Holtzman DM; Heneka MT
J Neurosci; 2011 May; 31(19):7049-59. PubMed ID: 21562267
[TBL] [Abstract][Full Text] [Related]
34. Apolipoprotein E deposition and astrogliosis are associated with maturation of beta-amyloid plaques in betaAPPswe transgenic mouse: Implications for the pathogenesis of Alzheimer's disease.
Terai K; Iwai A; Kawabata S; Sasamata M; Miyata K; Yamaguchi T
Brain Res; 2001 May; 900(1):48-56. PubMed ID: 11325345
[TBL] [Abstract][Full Text] [Related]
35. Novel App knock-in mouse model shows key features of amyloid pathology and reveals profound metabolic dysregulation of microglia.
Xia D; Lianoglou S; Sandmann T; Calvert M; Suh JH; Thomsen E; Dugas J; Pizzo ME; DeVos SL; Earr TK; Lin CC; Davis S; Ha C; Leung AW; Nguyen H; Chau R; Yulyaningsih E; Lopez I; Solanoy H; Masoud ST; Liang CC; Lin K; Astarita G; Khoury N; Zuchero JY; Thorne RG; Shen K; Miller S; Palop JJ; Garceau D; Sasner M; Whitesell JD; Harris JA; Hummel S; Gnörich J; Wind K; Kunze L; Zatcepin A; Brendel M; Willem M; Haass C; Barnett D; Zimmer TS; Orr AG; Scearce-Levie K; Lewcock JW; Di Paolo G; Sanchez PE
Mol Neurodegener; 2022 Jun; 17(1):41. PubMed ID: 35690868
[TBL] [Abstract][Full Text] [Related]
36. Combined Liver X Receptor/Peroxisome Proliferator-activated Receptor γ Agonist Treatment Reduces Amyloid β Levels and Improves Behavior in Amyloid Precursor Protein/Presenilin 1 Mice.
Skerrett R; Pellegrino MP; Casali BT; Taraboanta L; Landreth GE
J Biol Chem; 2015 Aug; 290(35):21591-602. PubMed ID: 26163517
[TBL] [Abstract][Full Text] [Related]
37. System Xc- and apolipoprotein E expressed by microglia have opposite effects on the neurotoxicity of amyloid-beta peptide 1-40.
Qin S; Colin C; Hinners I; Gervais A; Cheret C; Mallat M
J Neurosci; 2006 Mar; 26(12):3345-56. PubMed ID: 16554485
[TBL] [Abstract][Full Text] [Related]
38. L-type calcium channel antagonist isradipine age-dependently decreases plaque associated dystrophic neurites in 5XFAD mouse model.
Wickline JL; Smith S; Shin R; Odfalk K; Sanchez J; Javors M; Ginsburg B; Hopp SC
Neuropharmacology; 2023 Apr; 227():109454. PubMed ID: 36740015
[TBL] [Abstract][Full Text] [Related]
39. A Novel Apolipoprotein E Antagonist Functionally Blocks Apolipoprotein E Interaction With N-terminal Amyloid Precursor Protein, Reduces β-Amyloid-Associated Pathology, and Improves Cognition.
Sawmiller D; Habib A; Hou H; Mori T; Fan A; Tian J; Zeng J; Giunta B; Sanberg PR; Mattson MP; Tan J
Biol Psychiatry; 2019 Aug; 86(3):208-220. PubMed ID: 31208706
[TBL] [Abstract][Full Text] [Related]
40. The Alzheimer's disease risk factor INPP5D restricts neuroprotective microglial responses in amyloid beta-mediated pathology.
Samuels JD; Moore KA; Ennerfelt HE; Johnson AM; Walsh AE; Price RJ; Lukens JR
Alzheimers Dement; 2023 Nov; 19(11):4908-4921. PubMed ID: 37061460
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
